Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

8.7%

2 terminated/withdrawn out of 23 trials

Success Rate

84.6%

-1.9% vs industry average

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

9%

1 of 11 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A
8(50.0%)
Phase 2
6(37.5%)
Phase 3
2(12.5%)
16Total
N/A(8)
Phase 2(6)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT07486336Not ApplicableNot Yet Recruiting

Awareness Neuraxial Versus General Anesthesia in Frail Patients Undergoing Laparoscopic or Robotic Abdominopelvic Surgery.

Role: lead

NCT07483840Not ApplicableNot Yet Recruiting

Analgesic Techniques for Robotic Prostatectomy Procedures

Role: lead

NCT06982313Completed

Long-term Follow-up of the TAM-01 Study and Pooled Analysis of Low-dose Tamoxifen Studies in Non-invasive or Microinvasive Breast Neoplasms

Role: lead

NCT06994208Recruiting

Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.

Role: lead

NCT03840447Not ApplicableCompleted

Analysis of the Efficiency of a Chronic Disease Self-Management Programme in a Vulnerable Population in Five European Countries

Role: collaborator

NCT07187986Not ApplicableCompleted

Sound Acupuncture in Painful Chemotherapy-Related Neuropathies

Role: lead

NCT06033092Phase 2Active Not Recruiting

Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion

Role: collaborator

NCT04932863Completed

BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment

Role: lead

NCT05122052Completed

Effect of Gender on Distress and Fatigue in Cancer Patients

Role: lead

NCT06219304Not ApplicableRecruiting

Effect of High Intensity Training on Motor and Cognitive Functions

Role: collaborator

NCT05601700Phase 3Recruiting

Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)

Role: lead

NCT03047837Phase 2Terminated

A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients

Role: lead

NCT01948661Not ApplicableCompleted

Anthocyanin Extract and Phospholipid Curcumin in Colorectal Adenoma

Role: lead

NCT06601205Phase 2Completed

Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.

Role: lead

NCT04460807Phase 3Terminated

Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer

Role: lead

NCT00907283Phase 2Unknown

Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)

Role: lead

NCT05659979Not ApplicableUnknown

Comprehensive Geriatric Assessment in Knee Osteoarthritis

Role: collaborator

NCT01496963Completed

Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia

Role: lead

NCT01140321Phase 2Completed

Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI

Role: lead

NCT03293953Unknown

Prospective Comparison Between TE, SWE and MRE (FULLFIBRO01)

Role: lead